TERM ID="NYU_TERM_1" STRING="ACR" FREQUENCY=1 START=700 END=703 LEMMA="ACR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_2" STRING="CI" FREQUENCY=1 START=759 END=761 LEMMA="CI" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_3" STRING="Golimumab" FREQUENCY=1 START=0 END=9 LEMMA="GOLIMUMAB" LEMMA_FREQUENCY=11
TERM ID="NYU_TERM_4" STRING="HAQ" FREQUENCY=1 START=1182 END=1185 LEMMA="HEALTH ASSESSMENT QUESTIONNAIRE" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_5" STRING="HAQ change" FREQUENCY=1 START=2687 END=2697 LEMMA="HAQ CHANGE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_6" STRING="Health Assessment Questionnaire" FREQUENCY=2 START=1149 END=1180 LEMMA="HEALTH ASSESSMENT QUESTIONNAIRE" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_7" STRING="Health Assessment Questionnaire" FREQUENCY=2 START=1149 END=1180 LEMMA="HEALTH ASSESSMENT QUESTIONNAIRE" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_8" STRING="ICER" FREQUENCY=1 START=3815 END=3819 LEMMA="INCREMENTAL COST EFFECTIVENESS RATIO" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_9" STRING="ICERs" FREQUENCY=2 START=2838 END=2843 LEMMA="INCREMENTAL COST EFFECTIVENESS RATIOS" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_10" STRING="ICERs" FREQUENCY=2 START=3158 END=3163 LEMMA="INCREMENTAL COST EFFECTIVENESS RATIOS" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_11" STRING="MTC" FREQUENCY=1 START=1697 END=1700 LEMMA="MIXED TREATMENT COMPARISON" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_12" STRING="MTC analysis" FREQUENCY=3 START=1807 END=1819 LEMMA="MTC ANALYSIS" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_13" STRING="MTC analysis" FREQUENCY=3 START=1874 END=1886 LEMMA="MTC ANALYSIS" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_14" STRING="MTC analysis" FREQUENCY=3 START=2736 END=2748 LEMMA="MTC ANALYSIS" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_15" STRING="MTC analysis of RCT data" FREQUENCY=1 START=2736 END=2760 LEMMA="RCT DATA MTC ANALYSIS" LEMMA_FREQUENCY=1 HEAD_TERM="MTC analysis" HEAD_LEMMA="MTC ANALYSIS"
TERM ID="NYU_TERM_16" STRING="PASI" FREQUENCY=3 START=940 END=944 LEMMA="PASI" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_17" STRING="PASI" FREQUENCY=3 START=1358 END=1362 LEMMA="PASI" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_18" STRING="PASI" FREQUENCY=3 START=1370 END=1374 LEMMA="PASI" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_19" STRING="PASI change" FREQUENCY=1 START=2702 END=2713 LEMMA="PASI CHANGE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_20" STRING="PASI outcomes" FREQUENCY=1 START=1406 END=1419 LEMMA="PASI OUTCOME" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_21" STRING="PsA" FREQUENCY=1 START=191 END=194 LEMMA="PSORIATIC ARTHRITIS" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_22" STRING="PsARC" FREQUENCY=2 START=821 END=826 LEMMA="PSORIATIC ARTHRITIS RESPONSE CRITERIA" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_23" STRING="PsARC" FREQUENCY=2 START=2680 END=2685 LEMMA="PSORIATIC ARTHRITIS RESPONSE CRITERIA" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_24" STRING="Psoriasis Area" FREQUENCY=1 START=905 END=919 LEMMA="PSORIASIS AREA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_25" STRING="Psoriasis Area and Severity Index" FREQUENCY=1 START=905 END=938 LEMMA="PSORIASIS AREA AND SEVERITY INDEX" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_26" STRING="Psoriatic Arthritis Response Criteria" FREQUENCY=2 START=782 END=819 LEMMA="PSORIATIC ARTHRITIS RESPONSE CRITERION" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_27" STRING="Psoriatic Arthritis Response Criteria" FREQUENCY=2 START=782 END=819 LEMMA="PSORIATIC ARTHRITIS RESPONSE CRITERION" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_28" STRING="QALY" FREQUENCY=1 START=3842 END=3846 LEMMA="QUALITY ADJUSTED LIFE YEAR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_29" STRING="QALYs" FREQUENCY=1 START=3791 END=3796 LEMMA="QUALITY ADJUSTED LIFE YEARS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_30" STRING="RCT" FREQUENCY=1 START=300 END=303 LEMMA="RANDOMISED CONTROLLED TRIAL" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_31" STRING="RCT data" FREQUENCY=1 START=2752 END=2760 LEMMA="RCT DATA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_32" STRING="RR" FREQUENCY=3 START=724 END=726 LEMMA="RELATIVE RISK" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_33" STRING="RR" FREQUENCY=3 START=829 END=831 LEMMA="RELATIVE RISK" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_34" STRING="RR" FREQUENCY=3 START=950 END=952 LEMMA="RELATIVE RISK" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_35" STRING="Rheumatology" FREQUENCY=1 START=686 END=698 LEMMA="RHEUMATOLOGY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_36" STRING="Severity Index" FREQUENCY=1 START=924 END=938 LEMMA="SEVERITY INDEX" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_37" STRING="TNF" FREQUENCY=1 START=2253 END=2256 LEMMA="TUMOR NECROSIS FACTOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_38" STRING="acquisition cost" FREQUENCY=1 START=3904 END=3920 LEMMA="ACQUISITION COST" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_39" STRING="adalimumab" FREQUENCY=2 START=2435 END=2445 LEMMA="ADALIMUMAB" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_40" STRING="adalimumab" FREQUENCY=2 START=3698 END=3708 LEMMA="ADALIMUMAB" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_41" STRING="administration cost" FREQUENCY=1 START=3352 END=3371 LEMMA="ADMINISTRATION COST" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_42" STRING="ankylosing spondylitis" FREQUENCY=1 START=2126 END=2148 LEMMA="ANKYLOSING SPONDYLITI" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_43" STRING="anti-TNF agents" FREQUENCY=3 START=2652 END=2667 LEMMA="ANTI-TNF AGENT" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_44" STRING="anti-TNF agents" FREQUENCY=3 START=3563 END=3578 LEMMA="ANTI-TNF AGENT" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_45" STRING="anti-TNF agents" FREQUENCY=3 START=3632 END=3647 LEMMA="ANTI-TNF AGENT" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_46" STRING="anti-tumour necrosis factor" FREQUENCY=1 START=2224 END=2251 LEMMA="ANTI-TUMOUR NECROSIS FACTOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_47" STRING="antirheumatic drugs" FREQUENCY=1 START=474 END=493 LEMMA="ANTIRHEUMATIC DRUG" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_48" STRING="base-case model" FREQUENCY=1 START=2499 END=2514 LEMMA="BASE-CASE MODEL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_49" STRING="baseline" FREQUENCY=1 START=1199 END=1207 LEMMA="BASELINE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_50" STRING="biologics" FREQUENCY=2 START=3139 END=3148 LEMMA="BIOLOGIC" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_51" STRING="biologics" FREQUENCY=2 START=3947 END=3956 LEMMA="BIOLOGIC" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_52" STRING="clinical effectiveness" FREQUENCY=1 START=3308 END=3330 LEMMA="CLINICAL EFFECTIVENESS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_53" STRING="clinical effectiveness data" FREQUENCY=1 START=206 END=233 LEMMA="CLINICAL EFFECTIVENESS DATA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_54" STRING="cohort" FREQUENCY=1 START=2527 END=2533 LEMMA="COHORT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_55" STRING="comparing golimumab" FREQUENCY=1 START=2858 END=2877 LEMMA="COMPARING GOLIMUMAB" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_56" STRING="confidence interval" FREQUENCY=2 START=738 END=757 LEMMA="CONFIDENCE INTERVAL" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_57" STRING="confidence interval" FREQUENCY=2 START=738 END=757 LEMMA="CONFIDENCE INTERVAL" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_58" STRING="controlled trial" FREQUENCY=1 START=282 END=298 LEMMA="CONTROLLED TRIAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_59" STRING="cost-effective alternative" FREQUENCY=1 START=2919 END=2945 LEMMA="COST-EFFECTIVE ALTERNATIVE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_60" STRING="cost-effective treatment option" FREQUENCY=1 START=3013 END=3044 LEMMA="COST-EFFECTIVE TREATMENT OPTION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_61" STRING="cost-effectiveness" FREQUENCY=1 START=3541 END=3559 LEMMA="COST-EFFECTIVENESS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_62" STRING="cost-effectiveness of anti-TNF agents" FREQUENCY=1 START=3541 END=3578 LEMMA="ANTI-TNF AGENT COST-EFFECTIVENESS" LEMMA_FREQUENCY=1 HEAD_TERM="cost-effectiveness" HEAD_LEMMA="COST-EFFECTIVENESS"
TERM ID="NYU_TERM_63" STRING="crossover" FREQUENCY=1 START=1618 END=1627 LEMMA="CROSSOVER" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_64" STRING="decision model" FREQUENCY=1 START=2371 END=2385 LEMMA="DECISION MODEL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_65" STRING="disease response" FREQUENCY=1 START=634 END=650 LEMMA="DISEASE RESPONSE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_66" STRING="effect profile" FREQUENCY=1 START=2171 END=2185 LEMMA="EFFECT PROFILE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_67" STRING="effect profile of golimumab" FREQUENCY=1 START=2171 END=2198 LEMMA="GOLIMUMAB EFFECT PROFILE" LEMMA_FREQUENCY=1 HEAD_TERM="effect profile" HEAD_LEMMA="EFFECT PROFILE"
TERM ID="NYU_TERM_68" STRING="etanercept" FREQUENCY=2 START=2397 END=2407 LEMMA="ETANERCEPT" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_69" STRING="etanercept" FREQUENCY=2 START=2947 END=2957 LEMMA="ETANERCEPT" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_70" STRING="event data" FREQUENCY=1 START=2024 END=2034 LEMMA="EVENT DATA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_71" STRING="event data of golimumab" FREQUENCY=1 START=2024 END=2047 LEMMA="GOLIMUMAB EVENT DATA" LEMMA_FREQUENCY=1 HEAD_TERM="event data" HEAD_LEMMA="EVENT DATA"
TERM ID="NYU_TERM_72" STRING="evidence review group" FREQUENCY=1 START=88 END=109 LEMMA="EVIDENCE REVIEW GROUP" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_73" STRING="exchangeability" FREQUENCY=1 START=1749 END=1764 LEMMA="EXCHANGEABILITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_74" STRING="functional status" FREQUENCY=1 START=1112 END=1129 LEMMA="FUNCTIONAL STATUS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_75" STRING="golimumab" FREQUENCY=10 START=139 END=148 LEMMA="GOLIMUMAB" LEMMA_FREQUENCY=11
TERM ID="NYU_TERM_76" STRING="golimumab" FREQUENCY=10 START=589 END=598 LEMMA="GOLIMUMAB" LEMMA_FREQUENCY=11
TERM ID="NYU_TERM_77" STRING="golimumab" FREQUENCY=10 START=1938 END=1947 LEMMA="GOLIMUMAB" LEMMA_FREQUENCY=11
TERM ID="NYU_TERM_78" STRING="golimumab" FREQUENCY=10 START=2038 END=2047 LEMMA="GOLIMUMAB" LEMMA_FREQUENCY=11
TERM ID="NYU_TERM_79" STRING="golimumab" FREQUENCY=10 START=2189 END=2198 LEMMA="GOLIMUMAB" LEMMA_FREQUENCY=11
TERM ID="NYU_TERM_80" STRING="golimumab" FREQUENCY=10 START=2300 END=2309 LEMMA="GOLIMUMAB" LEMMA_FREQUENCY=11
TERM ID="NYU_TERM_81" STRING="golimumab" FREQUENCY=10 START=2421 END=2430 LEMMA="GOLIMUMAB" LEMMA_FREQUENCY=11
TERM ID="NYU_TERM_82" STRING="golimumab" FREQUENCY=10 START=2998 END=3007 LEMMA="GOLIMUMAB" LEMMA_FREQUENCY=11
TERM ID="NYU_TERM_83" STRING="golimumab" FREQUENCY=10 START=3087 END=3096 LEMMA="GOLIMUMAB" LEMMA_FREQUENCY=11
TERM ID="NYU_TERM_84" STRING="golimumab" FREQUENCY=10 START=3713 END=3722 LEMMA="GOLIMUMAB" LEMMA_FREQUENCY=11
TERM ID="NYU_TERM_85" STRING="health outcomes" FREQUENCY=1 START=3461 END=3476 LEMMA="HEALTH OUTCOME" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_86" STRING="incremental cost-effectiveness ratios" FREQUENCY=2 START=2799 END=2836 LEMMA="INCREMENTAL COST-EFFECTIVENESS RATIO" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_87" STRING="incremental cost-effectiveness ratios" FREQUENCY=2 START=2799 END=2836 LEMMA="INCREMENTAL COST-EFFECTIVENESS RATIO" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_88" STRING="infliximab" FREQUENCY=2 START=2409 END=2419 LEMMA="INFLIXIMAB" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_89" STRING="infliximab" FREQUENCY=2 START=3879 END=3889 LEMMA="INFLIXIMAB" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_90" STRING="intention-to-treat analysis" FREQUENCY=1 START=1468 END=1495 LEMMA="INTENTION-TO-TREAT ANALYSIS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_91" STRING="key area" FREQUENCY=1 START=3513 END=3521 LEMMA="KEY AREA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_92" STRING="life-years" FREQUENCY=1 START=3779 END=3789 LEMMA="LIFE-YEAR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_93" STRING="longer-term data" FREQUENCY=1 START=1984 END=2000 LEMMA="LONGER-TERM DATA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_94" STRING="longer-term safety profile" FREQUENCY=1 START=2270 END=2296 LEMMA="LONGER-TERM SAFETY PROFILE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_95" STRING="longer-term safety profile of golimumab" FREQUENCY=1 START=2270 END=2309 LEMMA="GOLIMUMAB LONGER-TERM SAFETY PROFILE" LEMMA_FREQUENCY=1 HEAD_TERM="longer-term safety profile" HEAD_LEMMA="LONGER-TERM SAFETY PROFILE"
TERM ID="NYU_TERM_96" STRING="manufacturer" FREQUENCY=7 START=1644 END=1656 LEMMA="MANUFACTURER" LEMMA_FREQUENCY=7
TERM ID="NYU_TERM_97" STRING="manufacturer" FREQUENCY=7 START=1953 END=1965 LEMMA="MANUFACTURER" LEMMA_FREQUENCY=7
TERM ID="NYU_TERM_98" STRING="manufacturer" FREQUENCY=7 START=2332 END=2345 LEMMA="MANUFACTURER" LEMMA_FREQUENCY=7
TERM ID="NYU_TERM_99" STRING="manufacturer" FREQUENCY=7 START=2766 END=2778 LEMMA="MANUFACTURER" LEMMA_FREQUENCY=7
TERM ID="NYU_TERM_100" STRING="manufacturer" FREQUENCY=7 START=2971 END=2984 LEMMA="MANUFACTURER" LEMMA_FREQUENCY=7
TERM ID="NYU_TERM_101" STRING="manufacturer" FREQUENCY=7 START=3049 END=3062 LEMMA="MANUFACTURER" LEMMA_FREQUENCY=7
TERM ID="NYU_TERM_102" STRING="manufacturer" FREQUENCY=7 START=3242 END=3254 LEMMA="MANUFACTURER" LEMMA_FREQUENCY=7
TERM ID="NYU_TERM_103" STRING="mg" FREQUENCY=1 START=602 END=604 LEMMA="MG" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_104" STRING="mixed treatment comparison" FREQUENCY=1 START=1669 END=1695 LEMMA="MIXED TREATMENT COMPARISON" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_105" STRING="non-steroidal anti-inflammatory drugs" FREQUENCY=1 START=497 END=534 LEMMA="NON-STEROIDAL ANTI-INFLAMMATORY DRUG" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_106" STRING="open-label extension data" FREQUENCY=1 START=1244 END=1269 LEMMA="OPEN-LABEL EXTENSION DATA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_107" STRING="palliative care" FREQUENCY=3 START=2453 END=2468 LEMMA="PALLIATIVE CARE" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_108" STRING="palliative care" FREQUENCY=3 START=2883 END=2898 LEMMA="PALLIATIVE CARE" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_109" STRING="palliative care" FREQUENCY=3 START=3854 END=3869 LEMMA="PALLIATIVE CARE" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_110" STRING="progressive PsA" FREQUENCY=1 START=391 END=406 LEMMA="PROGRESSIVE PSA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_111" STRING="psoriasis" FREQUENCY=1 START=2579 END=2588 LEMMA="PSORIASI" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_112" STRING="psoriatic arthritis" FREQUENCY=3 START=170 END=189 LEMMA="PSORIATIC ARTHRITIS" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_113" STRING="psoriatic arthritis" FREQUENCY=3 START=31 END=50 LEMMA="PSORIATIC ARTHRITIS" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_114" STRING="psoriatic arthritis" FREQUENCY=3 START=170 END=189 LEMMA="PSORIATIC ARTHRITIS" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_115" STRING="quality-adjusted life-years" FREQUENCY=1 START=3762 END=3789 LEMMA="QUALITY-ADJUSTED LIFE-YEAR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_116" STRING="randomised controlled trial" FREQUENCY=1 START=271 END=298 LEMMA="RANDOMISED CONTROLLED TRIAL" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_117" STRING="regarding uncertainty" FREQUENCY=1 START=3266 END=3287 LEMMA="REGARDING UNCERTAINTY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_118" STRING="relative risk" FREQUENCY=1 START=709 END=722 LEMMA="RELATIVE RISK" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_119" STRING="rheumatoid arthritis" FREQUENCY=1 START=2101 END=2121 LEMMA="RHEUMATOID ARTHRITIS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_120" STRING="sensitivity analyses" FREQUENCY=1 START=3202 END=3222 LEMMA="SENSITIVITY ANALYSIS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_121" STRING="statistical approach" FREQUENCY=1 START=1846 END=1866 LEMMA="STATISTICAL APPROACH" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_122" STRING="treating patients" FREQUENCY=1 START=357 END=374 LEMMA="TREATING PATIENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_123" STRING="treating psoriasis" FREQUENCY=1 START=3394 END=3412 LEMMA="TREATING PSORIASI" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_124" STRING="treatment benefits" FREQUENCY=1 START=1027 END=1045 LEMMA="TREATMENT BENEFIT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_125" STRING="treatment comparison" FREQUENCY=1 START=1675 END=1695 LEMMA="TREATMENT COMPARISON" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_126" STRING="treatment contamination" FREQUENCY=1 START=1579 END=1602 LEMMA="TREATMENT CONTAMINATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_127" STRING="tumour necrosis factor" FREQUENCY=1 START=2229 END=2251 LEMMA="TUMOUR NECROSIS FACTOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_128" STRING="utility functions" FREQUENCY=1 START=3421 END=3438 LEMMA="UTILITY FUNCTION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_129" STRING="week" FREQUENCY=1 START=1631 END=1635 LEMMA="WEEK" LEMMA_FREQUENCY=1
